Aldehyde Dehydrogenase (ALDH)
Read More about this categoryShow Less
Aldehyde dehydrogenase 1 (ALDH1), which is a putative marker of breast cancer stem cells (CSCs), in triple negative breast cancer (TNBC) tissues.
Mitochondrial aldehyde dehydrogenase (ALDH2) is a member of the 19-strong human aldehyde dehydrogenase family of NADP+-dependent enzymes.
ALDH2, a mitochondrial enzyme responsible for metabolizing the major lipid peroxidation product, protects against acute ischemia/reperfusion injury and chronic heart failure. Activation of ALDH2, the main enzyme that catalyzes 4-HNE metabolism, is sufficient to protect the heart against acute ischemia-reperfusion injury.
ALDH2 is a key detoxifying enzyme. ALDH2 is most commonly associated with its role in ethanol metabolism, catalyzing the oxidation of ethanol-derived acetaldehyde to acetate.
Products Related to Aldehyde Dehydrogenase (ALDH)(31)
- GC392454-DiethylaminobenzaldehydeCAS: 120-21-8Purity: >98.00%
4-Diethylaminobenzaldehyde is a reversible aldehyde dehydrogenases (ALDHs) inhibitor, with a Ki of 4 nM for ALDH1. 4-Diethylaminobenzaldehyde displays potent anti-androgenic effect (IC50= 1.71μM).
- GC393283-HydroxybenzaldehydeCAS: 100-83-4Purity: >98.00%
3-Hydroxybenzaldehyde?is a precursor compound for phenolic compounds, such as Protocatechualdehyde.
- GC424104-hydroxy NonenalCAS: 75899-68-2Purity: >97.00%
4-Hydroxy Nonenal (4-HNE) is a product of lipid peroxidation (LPO), an α,β-unsaturated hydroxyalkenal formed from the oxidation of ω-6 polyunsaturated fatty acids, it is a colorless oil.
- GC44338NCT-501 (hydrochloride)CAS: 2080306-22-3Purity: >98.00%
Aldehyde dehydrogenases (ALDHs) catalyze the NAD(P)+-dependent oxidation of aldehyde-containing substrates to the corresponding carboxylic acids.
- GC60092BODIPY aminoacetaldehydeCAS: 247069-94-9Purity: >98%
BODIPY aminoacetaldehyde (BAAA) is a fluorescent substrate for both murine and human aldehyde dehydrogenase (ALDH). BODIPY aminoacetaldehyde consists of an aminoacetaldehyde moiety bonded to the BODIPY fluorochrome and can be used to label stem cells.
- GC64063ALDH1A1-IN-2CAS: 2231081-18-6Purity: >98%
ALDH1A1-IN-2 is a potent inhibitor of aldehyde dehydrogenase 1a1 (aldh1a1). Aldehyde dehydrogenases (ALDH) constitute a family of enzymes that play a critical role in oxidizing various cytotoxic xenogenic and biogenic aldehydes. ALDH1A1-IN-2 has the potential for the research of cancer, inflammation, or obesity (extracted from patent WO2019089626A1, compound 295).
- GC64618ALDH1A3-IN-3CAS: 18962-05-5Purity: >99.00%
ALDH1A3-IN-3 (compound 16) is a potent inhibitor of ALDH1A3, with an IC50 of 0.26 μM. ALDH1A3-IN-3 is also a good ALDH3A1 substrate. ALDH1A3-IN-3 can be used for the research of prostate cancer.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC10016 | NCT-501 | 1802088-50-1 | >99.50% | |
Aldehyde Dehydrogenase 1A1 (ALDH1A1) inhibitor, Potent and Selective | ||||
| GC10801 | Disulfiram | 97-77-8 | >99.50% | |
An irreversible inhibitor of aldehyde dehydrogenase | ||||
| GC10902 | CVT 10216 | 1005334-57-5 | >99.00% | |
CVT 10216 is a highly selective, reversible inhibitor of aldehyde dehydrogenase-2 (ALDH-2), with IC 50 values of 29nM and 1.3μM for ALDH-2 and ALDH-1, respectively. | ||||
| GC16597 | Alda 1 | 349438-38-6 | >99.50% | |
Alda 1 is an aldehyde dehydrogenase 2 (ALDH2) activator. | ||||
| GC33219 | NCT-505 | 2231079-74-4 | >98% | |
NCT-505 is a potent and selective aldehyde dehydrogenase (ALDH1A1) inhibitor, with an IC50 of 7 nM, and weakly inhibits hALDH1A2, hALDH1A3, hALDH2, hALDH3A1 (IC50s, >57, 22.8, 20.1, >57 μM). | ||||
| GC37576 | RV01 | 1016897-10-1 | >98.00% | |
RV01 is an analogue of resveratrol, inhibits DNA damage, reduces acetaldehyde dehydrogenase 2 (ALDH2) mRNA expression induced by ethanol, and exhibits hydroxyl radical scavenging activity. | ||||
| GC38909 | EN40 | 2094547-67-6 | >98% | |
EN40 is a potent, selective aldehyde dehydrogenase 3A1 (ALDH3A1) inhibitor as a covalent ligand, exhibits an IC50 value of 2 uM | ||||
| GC39215 | CM10 | 692269-09-3 | >99.50% | |
CM10 is a potent and selective aldehyde dehydrogenase 1A (ALDH1A) family inhibitor, with IC50s of 1700, 740, and 640 nM for ALDH1A1, ALDH1A2, and ALDH1A3, respectively. | ||||
| GC39245 | 4-Diethylaminobenzaldehyde | 120-21-8 | >98.00% | |
4-Diethylaminobenzaldehyde is a reversible aldehyde dehydrogenases (ALDHs) inhibitor, with a Ki of 4 nM for ALDH1. 4-Diethylaminobenzaldehyde displays potent anti-androgenic effect (IC50= 1.71μM). | ||||
| GC39328 | 3-Hydroxybenzaldehyde | 100-83-4 | >98.00% | |
3-Hydroxybenzaldehyde?is a precursor compound for phenolic compounds, such as Protocatechualdehyde. | ||||
| GC42410 | 4-hydroxy Nonenal | 75899-68-2 | >97.00% | |
4-Hydroxy Nonenal (4-HNE) is a product of lipid peroxidation (LPO), an α,β-unsaturated hydroxyalkenal formed from the oxidation of ω-6 polyunsaturated fatty acids, it is a colorless oil. | ||||
| GC43285 | CM037 | 896795-60-1 | >98.00% | |
CM037 is a selective inhibitor of aldehyde dehydrogenase 1A1 (ALDH1A1; IC50 = 4.6 μM). | ||||
| GC44338 | NCT-501 (hydrochloride) | 2080306-22-3 | >98.00% | |
Aldehyde dehydrogenases (ALDHs) catalyze the NAD(P)+-dependent oxidation of aldehyde-containing substrates to the corresponding carboxylic acids. | ||||
| GC46002 | Prunetin | 552-59-0 | >95.00% | |
An isoflavone with diverse biological activities | ||||
| GC50613 | 673 A | 109437-62-9 | >98% | |
ALDH1A inhibitor; depletes CD133+ cancer stem cells (CSC) | ||||
| GC60092 | BODIPY aminoacetaldehyde | 247069-94-9 | >98% | |
BODIPY aminoacetaldehyde (BAAA) is a fluorescent substrate for both murine and human aldehyde dehydrogenase (ALDH). BODIPY aminoacetaldehyde consists of an aminoacetaldehyde moiety bonded to the BODIPY fluorochrome and can be used to label stem cells. | ||||
| GC63605 | Taraxerone | 514-07-8 | >98% | |
Taraxerone is isolated from Sedum sarmentosum. | ||||
| GC64063 | ALDH1A1-IN-2 | 2231081-18-6 | >98% | |
ALDH1A1-IN-2 is a potent inhibitor of aldehyde dehydrogenase 1a1 (aldh1a1). Aldehyde dehydrogenases (ALDH) constitute a family of enzymes that play a critical role in oxidizing various cytotoxic xenogenic and biogenic aldehydes. ALDH1A1-IN-2 has the potential for the research of cancer, inflammation, or obesity (extracted from patent WO2019089626A1, compound 295). | ||||
| GC64618 | ALDH1A3-IN-3 | 18962-05-5 | >99.00% | |
ALDH1A3-IN-3 (compound 16) is a potent inhibitor of ALDH1A3, with an IC50 of 0.26 μM. ALDH1A3-IN-3 is also a good ALDH3A1 substrate. ALDH1A3-IN-3 can be used for the research of prostate cancer. | ||||
| GC65274 | NCT-506 | 2231098-99-8 | >99.00% | |
NCT-506 is an orally bioavailable aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with an IC50 of 7 nM. | ||||
| GC67782 | ALDH1A2-IN-1 | 2204229-64-9 | >98.00% | |
| GC68009 | KS106 | 2408477-50-7 | >98% | |
| GC68462 | ALDH1A3-IN-2 | 886502-08-5 | >98% | |
| GC68464 | ALDH1A3-IN-1 | 1695970-90-1 | >98% | |
